|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.56 CNY | +3.58% |
|
+0.34% | +9.01% |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
Biotechnology | 1.44B | 1.2B | 1.07B | 1.82B | 1.23B | ||
Total Assets | 2.47B | 4.17B | 4.28B | 5.05B | 5.2B | ||
Interest Expense | -4.05M | -329K | - | -705K | -1.52M | ||
Income Tax Expense | 68.42M | 18.01M | 16.16M | 62.75M | 23.68M | ||
CAPEX | -336M | -633M | -291M | -471M | -542M | ||
EBT | 487M | 262M | 198M | 564M | 256M | ||
D&A | 58.86M | 68.34M | 70.94M | 91.99M | 104M | ||
Operating Income | 482M | 262M | 187M | 559M | 258M | ||
Net Income | 418M | 244M | 182M | 501M | 232M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
Eastern Region | 515M | 385M | 340M | 502M | 339M | ||
Central China | 259M | 152M | 134M | 290M | 204M | ||
Southern Region | 212M | 208M | 217M | 282M | 203M | ||
Southwest | 183M | 144M | 139M | 281M | 198M | ||
Northern Region | 103M | 118M | 95.58M | 195M | 124M | ||
North-West Area | 89.81M | 121M | 86.52M | 142M | 82.14M | ||
Northeast District | 69.7M | 50.86M | 39.25M | 96.42M | 53.92M | ||
Foreign | 8.44M | 18.21M | 20.16M | 35.16M | 26.07M | ||
Hong Kong, Macao and Taiwan | - | 5M | - | - | - |
- Stock Market
- Equities
- 688276 Stock
- Financials Changchun BCHT Biotechnology Co.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition